Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RRM1 | P23921 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.37 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28709094 | 1.00 | RRM1 (0.44) | RRM1SIGMAR1KMT2ABCHESCN8A | |
| SCHEMBL28711070 | 0.81 | RRM1 (0.47) | RRM1SIGMAR1KMT2ACALM1 | |
| SCHEMBL28702700 | 0.81 | RRM1 (0.47) | RRM1SIGMAR1KMT2ACALM1 | |
| SCHEMBL28711071 | 0.81 | RRM1 (0.47) | RRM1SIGMAR1KMT2ACALM1 | |
| SCHEMBL28702699 | 0.81 | RRM1 (0.47) | RRM1SIGMAR1KMT2ACALM1 | |
| Hydrochloric Acid SCHEMBL28715442 | 0.80 | RRM1 (0.46) | RRM1SIGMAR1KMT2ACALM1 | |
| Hydrochloric Acid SCHEMBL28715444 | 0.80 | RRM1 (0.46) | RRM1SIGMAR1KMT2ACALM1 | |
| SCHEMBL28715380 | 0.79 | RRM1 (0.48) | RRM1SIGMAR1KMT2A | |
| SCHEMBL28715381 | 0.79 | RRM1 (0.48) | RRM1SIGMAR1KMT2A | |
| SCHEMBL28715330 | 0.78 | KMT2A (0.50) | RRM1SIGMAR1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12338203-B2 | Urea compound for antagonizing LPA1 receptor | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2025-06-24 | — | — | US | disclosed |
| CN-119823001-A | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2025-04-15 | — | — | CN | disclosed |
| CN-114206832-B | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2025-04-04 | — | — | CN | disclosed |
| CN-114206832-A | Urea compounds antagonizing LPA1 receptor | 大正制药株式会社 | 2022-03-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12338203-B2 | Urea compound for antagonizing LPA1 receptor | LPAR1, LPAR2, LPAR3 | RRM1 3843/4885SIGMAR1 236/4885KMT2A 2533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.